5 reports

THE DRUG CANDIDATE IS A ## MER PEPTIDE ACTS BY TARGETING PROGRAMMED CELL DEATH ## LIGAND ## (PD-L##).

  • Blood Disease
  • Cardiovascular Disease
  • Cell Therapy
  • Therapy
  • Bristol-Myers Squibb Company

THE ALLERGY AND IMMUNOLOGY CENTER IS HOME TO NATIONALLY AND INTERNATIONALLY RENOWNED EXPERTS AND RESEARCHERS WHO ARE ON THE FOREFRONT OF EVALUATING NEW METHODS OF ALLERGY TESTING AND TREATMENT, AND PAVING THE WAY IN THE FIELDS OF FOOD ALLERGY, DRUG

  • Cardiovascular Disease
  • Healthcare
  • Medical Device
  • Respiratory Device
  • Market Size

EDEMA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2017* PROMINENT DRUGS EDEMA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2017* EDEMA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS B

  • Cardiology
  • Cardiovascular Disease
  • Respiratory Device
  • World
  • Product Initiative
  • HYPERTENSION - PIPELINE BY NIPPON SHINYAKU CO LTD

The company offers a wide range of drugs including drugs for pain, inflammation, and allergies; drugs for urological diseases; drugs for hematologic malignancies; drugs for gastrointestinal disorders; drugs for cardiovascular and metabol

  • Cardiovascular Disease
  • Pharmaceutical
  • Company
  • Product Initiative
  • Novartis AG

In September 2014, National Institute of Allergy and Infectious Diseases in collaboration with Immune Tolerance Network (ITN) registered a Phase I/ II study of AMG-## to find out if cat allergy shots with combination with AMG- ##, an experimental medication, will help the cat

  • Blood Disease
  • Cardiovascular Disease
  • Monoclonal Antibody
  • Therapy
  • Amgen Inc.